Cancer Research · 2007 · 126 citations · 19 references
MedicineCell BiologyOncologyCarcinogenesisMolecular OncologyTumor MicroenvironmentCancer Cell SignalingCytokine BiologyCytokine SignalingMacrophage BiologyTumor-associated MacrophagesTumor-stroma InteractionsCancer-associated MacrophagesColony-stimulating Factor 1 SignalingCytokine Expression RegulationCytokine Signaling In CancerCytokine Signaling In TumorsMacrophage ProliferationTumor-associated CytokinesVascular Endothelial Growth Factor
The interplay between malignant and stromal cells is essential in tumorigenesis. We have previously shown that colony-stimulating factor (CSF)-1, matrix metalloprotease (MMP)-2, and vascular endothelial growth factor (VEGF)-A production by stromal cells is enhanced by CSF-1-negative SW620 colon cancer cells. In the present study, the mechanisms by which colon cancer cells up-regulate host factors to promote tumorigenesis were investigated. Profiling of tumor cell cytokine expression in SW620 tumor xenografts in nude mice showed increased human tumor necrosis factor (TNF)-alpha mRNA expression with tumor growth. Incubation of macrophages with small interfering (si) RNAs directed against TNF-alpha or TNF-alpha-depleted SW620 cell conditioned medium versus SW620 cell conditioned medium failed to support mouse macrophage proliferation, migration, and expression of CSF-1, VEGF-A, and MMP-2 mRNAs. Consistent with these results, human TNF-alpha gene silencing decreased mouse macrophage TNF-alpha, CSF-1, MMP-2, and VEGF-A mRNA expression in macrophages cocultured with human cancer cells. In addition, inhibition of human TNF-alpha or mouse CSF-1 expression by siRNA reduced tumor growth in SW620 tumor xenografts in mice. These results suggest that colon cancer cell-derived TNF-alpha stimulates TNF-alpha and CSF-1 production by macrophages, and that CSF-1, in turn, induces macrophage VEGF-A and MMP-2 in an autocrine manner. Thus, interrupting tumor cell-macrophage communication by targeting TNF-alpha may provide an alternative therapeutic approach for the treatment of colon cancer.
19
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Robert J. Moore, David M. Owens, Gordon Stamp et al. · Nature Medicine · 1999 · 836 citations
Medicine, Dermatology, Oncology +12